Tru Independence LLC Regeneron Pharmaceuticals, Inc. Transaction History

Tru Independence LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 20, 2021	SELL	$446.73 - $548.2 $5,360 - $6,578	-12 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$478.3 - $607.98 $1,434 - $1,823	3 Added 33.33%	12 $5,000
Q3 2020 Nov 19, 2020	SELL	$544.75 - $658.21 $8,171 - $9,873	-15 Reduced 62.5%	9 $5,000
Q4 2019 May 19, 2020	BUY	$274.13 - $376.51 $6,579 - $9,036	24 New	24 $11,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence LLC with notifications on news.